📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Arch Oncology

1.1 - Company Overview

Arch Oncology Logo

Arch Oncology

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of venture-stage biopharmaceutical solutions.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Arch Oncology

MultiCell Technologies Logo

MultiCell Technologies

HQ: United States Website
  • Description: Provider of biopharmaceutical solutions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full MultiCell Technologies company profile →
Tubulis Logo

Tubulis

HQ: Germany Website
  • Description: Provider of chemotherapeutic medications for cancer and chronic disorders, developing disease-matched protein-drug conjugates (ADCs) using proprietary P5 conjugation chemistry and the Tubutecan linker-payload platform. Products include TUB-030 targeting 5T4 in solid tumors for long-lasting anti-tumor activity and TUB-040 targeting NaPi2b in ovarian and lung cancer for stable, potent delivery.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Tubulis company profile →
Thallion Pharmaceuticals Logo

Thallion Pharmaceuticals

HQ: Canada Website
  • Description: Provider of biotechnology-based pharmaceutical development in infectious disease and oncology, currently emphasizing treatment for Shigatoxin-producing E. coli (STEC) bacterial infections; leading product candidate is Shigamabs®, a dual antibody.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Thallion Pharmaceuticals company profile →
BioVaxys Logo

BioVaxys

HQ: Canada Website
  • Description: Provider of immunotherapeutic cancer vaccines and delivery platforms. Haptenix uses haptens to train the immune system to recognize tumor or viral proteins; DPX is a lipid-based system for enhanced, sustained immune responses. Pipeline includes BVX-0918 (Phase I ovarian), Maveropepimut-S (DPX-formulated, Phase II for various cancers), and DPX SurMAGE (survivin/MAGE A9; bladder, lung, kidney; Phase I complete).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full BioVaxys company profile →
Eureka Therapeutics Logo

Eureka Therapeutics

HQ: United States Website
  • Description: Provider of T-cell therapies via the ARTEMIS Cell Receptor Platform to engineer T cells to target and destroy cancer cells; the E-ALPHA Phage Display Platform to generate specific antibodies against cancer targets, including TCR-mimic antibodies for solid tumors; and an Expanded Access Policy offering investigational cell therapy under certain conditions to patients with serious or life-threatening diseases who have no other treatment options.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Eureka Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Arch Oncology

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Arch Oncology

2.2 - Growth funds investing in similar companies to Arch Oncology

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Arch Oncology

4.2 - Public trading comparable groups for Arch Oncology

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Arch Oncology

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Arch Oncology

What does Arch Oncology do?

Arch Oncology is a provider of venture-stage biopharmaceutical solutions.

Who are Arch Oncology's competitors?

Arch Oncology's competitors and similar companies include MultiCell Technologies, Tubulis, Thallion Pharmaceuticals, BioVaxys, and Eureka Therapeutics.

Where is Arch Oncology headquartered?

Arch Oncology is headquartered in United States.

How many employees does Arch Oncology have?

Arch Oncology has 1,000 employees 🔒.

When was Arch Oncology founded?

Arch Oncology was founded in 2010 🔒.

What sector and industry vertical is Arch Oncology in?

Arch Oncology is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Arch Oncology

Who are the top strategic acquirers in Arch Oncology's sector and industry

Top strategic M&A buyers and acquirers in Arch Oncology's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Arch Oncology?

Top strategic M&A buyers groups and sectors for Arch Oncology include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Arch Oncology's sector and industry vertical

Which are the top PE firms investing in Arch Oncology's sector and industry vertical?

Top PE firms investing in Arch Oncology's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Arch Oncology's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Arch Oncology's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Arch Oncology's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Arch Oncology include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Arch Oncology's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Arch Oncology?

The key public trading comparables and valuation benchmarks for Arch Oncology include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Arch Oncology for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Arch Oncology with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Arch Oncology's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Arch Oncology with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Arch Oncology's' sector and industry vertical?

Access recent funding rounds and capital raises in Arch Oncology's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Arch Oncology